tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
VIR
Vir Biotechnology
RESEARCH TOOLSreports

Vir Biotechnology (VIR) Stock News & Sentiment

Compare
1,463 Followers
Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating
Premium
Ratings
Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating
3d ago
VIR
Vir Biotechnology advances hepatitis delta program and cash runway
Premium
Company Announcements
Vir Biotechnology advances hepatitis delta program and cash runway
4d ago
8K
VIR
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
17d ago
VIR
EVMN
Vir Biotechnology: Norgine Partnership Extends Cash Runway and De‑Risks HDV Franchise, Supporting Buy Rating and $15 Target
Premium
Ratings
Vir Biotechnology: Norgine Partnership Extends Cash Runway and De‑Risks HDV Franchise, Supporting Buy Rating and $15 Target
17d ago
VIR
Vir Biotechnology: Strong HDV Performance and Strategic Partnership Drive Buy Rating
Premium
Ratings
Vir Biotechnology: Strong HDV Performance and Strategic Partnership Drive Buy Rating
30d ago
VIR
Strategic Partnership Enhances Vir Biotechnology’s Financial Outlook and European Market Opportunities
Premium
Ratings
Strategic Partnership Enhances Vir Biotechnology’s Financial Outlook and European Market Opportunities
30d ago
VIR
Vir Biotechnology Secures Licensing Deal with Norgine
Premium
Company Announcements
Vir Biotechnology Secures Licensing Deal with Norgine
1M ago
8K
VIR
More VIR News >

VIR News on the Web

H.C. Wainwright says Vir's SOLSTICE 96-week data reinforces best-in-class
The Fly
Neutral
Why Vir Biotechnology, Inc.’s (VIR) Stock Is Up 5.21%
AAII
Neutral
Why Vir Biotechnology, Inc.’s (VIR) Stock Is Down 5.25%
AAII
Neutral
Mirum's deal for Bluejay a positive readthrough to Vir, says Needham
The Fly
Neutral
Is Alnylam Pharmaceuticals a Millionaire Maker?
The Motley Fool
Neutral
Why Vir Biotechnology, Inc.’s (VIR) Stock Is Down 7.15%
AAII
Neutral
Why Vir Biotechnology, Inc.’s (VIR) Stock Is Down 8.57%
AAII
Neutral
Why Vir Biotechnology, Inc.’s (VIR) Stock Is Down 5.14%
AAII
Neutral

News Score - Last 7 Days

Neutral
VIR
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VIR’s Media Buzz Sentiment?
1 articles about VIR were published this week. In an average week, 1 articles are published.
    What is VIR’s weekly average amount of articles?
    In an average week, 1 articles about VIR are published.
      What is VIR’s News Sentiment?
      50% of articles about VIR were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        ALKSAlkermes
        WSTWest Pharmaceutical Services
        NYXHNyxoah
        PENPenumbra
        AGENAgenus
        Showing the stocks with the most bullish news sentiment over the past week